KIRKLAND, QC, May 31, 2011 /CNW Telbec/ – Today, Merck announced that Health Canada has approved a new indication for GARDASIL® [Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine] for the prevention of anal cancer in both men and women caused by HPV types 16 and 18 and anal precancerous lesions caused by […]